Advertisement
![Picture [iito] Männer Ballett 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-maenner-ballett.jpg)
Document › Details
Eppendorf AG. (4/5/19). "Press Release: Eppendorf AG Increases Sales and Earnings in 2018 and Accelerates Organic Growth". Hamburg.
> Sales increase by 5.6% to €729.2 million (8.2% in local currencies)
> Income from operations increased to €153.7 million
> EBIT margin constant at 21.1%
> Growth in all market regions and product groups
2018 was a very good fiscal year for the Eppendorf Group. The globally operating Hamburg-based life sciences company increased its Group sales by 5.6% (organic growth in local currencies +8.2%) to €729.2 million (previous year: €690.3 million). Income from operations (EBIT) rose by 5.6% to €153.7 million (previous year: €145.5 million). This corresponds to an EBIT margin of 21.1% (previous year: 21.1%). All major product groups and all market regions contributed to this positive development.
"Eppendorf achieved a very good result in 2018 in a dynamic market environment. It is particularly pleasing that we have once again grown faster than the market environment," says Thomas Bachmann, President and Chief Executive Officer of Eppendorf AG. "The company developed positively in all markets and thus consistently continued its profitable growth course. We achieved the targets we had set ourselves and at the same time pushed ahead with the strategic realignment of Eppendorf. This is a very good performance by all employees worldwide."
In North and South America, sales growth in local currencies amounted to 9.0%, the average industry growth in the region was clearly exceeded. North America in particular contributed to Eppendorf outperforming the market. Europe also posted very good growth rates with sales growth of 5.7% in local currencies. The strongest growth of 11.1% in local currencies was recorded in the Asia/Pacific/Africa region. All countries in this region contributed to the very good business development, with growth rates in China and India being particularly noteworthy.
In 2018, numerous measures, projects and initiatives in the areas of market development, portfolio management, infrastructure and corporate culture were implemented as part of the realignment of Eppendorf. They set the course for the company's successful future and put the new global organization into effect. This will enable Eppendorf to gear itself even better to the needs of the various markets and customers in the future. This also includes a comprehensive innovation initiative, within the framework of which numerous pilot projects for the product development have been carried out. In 2018, as in the previous year, Eppendorf significantly increased its expenditure on research and development. At €45.3 million (previous year: €36.5 million), these reached a new record level.
Outlook
The Eppendorf Group is striving for further sustainable growth also for fiscal year 2019. The company assumes that the positive economic mood in the industry and particularly in the USA will be maintained in 2019. Numerous product launches are planned for the first half of the year, which will contribute to the positive sales trend. As part of the targeted implementation of the corporate strategy, disproportionately high investments will continue to be made and the basis for further profitable and sustainable growth will be consolidated. Based on the planned higher costs, we estimate our EBIT will remain at the same level as the year before, given comparable exchange rates.
As of April 23, 2019, the Annual Report 2018 of Eppendorf AG can be found at:
corporate.eppendorf.com/en/company/annual report/
About Eppendorf AG
Eppendorf is a leading life science company that develops and sells instruments, consumables and services for liquid handling, sample handling and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators, shakers and cell manipulation systems. Consumables such as pipette tips, test tubes, microliter plates, and single-use bioreactor vessels complement the range of highest-quality premium products.
Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics and at industrial laboratories performing process analysis, production and quality assurance.
Eppendorf was founded in Hamburg, Germany in 1945 and has more than 3,300 employees worldwide. The company has subsidiaries in 26 countries and is represented in all important markets by distributors.
Record changed: 2019-04-16 |
Advertisement

More documents for Eppendorf (Group)
- [1] Eppendorf AG. (8/25/20). "Press Release: Eppendorf AG Records Strong First Half-year 2020. Consolidated Revenue Grows by 6.6% to €403.7 Million in the First Six Months > Consolidated revenue grows by 6.6% to €403.7 million in the first six months". Hamb...
- [2] Sysmex Inostics GmbH. (6/17/20). "Press Release: New CEO & President at Sysmex Inostics GmbH". Hamburg....
- [3] Eppendorf AG. (6/2/20). "Press Release: Supervisory Board Appoints New Chief Financial Officer. Axel Jaeger Becomes New Chief Financial Officer of Eppendorf AG". Hamburg....
- [4] Eppendorf AG. (5/15/20). "Press Release: Eppendorf Significantly Expands Capacities for the Production of Consumables". Hamburg & Oldenburg in Holstein....
- [5] Eppendorf AG. (4/20/20). "Press Release: Eppendorf AG Posts a Strong Fiscal Year 2019. Revenue Rises to €803.9 Million (Prior Year: €729.2 Million)". Hamburg....
- [6] Eppendorf AG. (3/19/20). "Press Release: Eppendorf Acquires Centrifuge Business of Koki Holdings Co., Ltd.". Hamburg & Tokyo....
- [7] Eppendorf AG. (12/6/19). "Press Release: Eppendorf with New CEO Dual Leadership. Eva van Pelt and Dr. Peter Fruhstorfer Appointed Co-CEOs – Former CEO, Thomas Bachmann, Left the Company". Hamburg....
- [8] Eppendorf AG. (9/26/19). "Press Release: Eppendorf Significantly Expands Production Site in Oldenburg". Hamburg & Oldenburg in Holstein....
- [9] Eppendorf AG. (8/20/19). "Press Release: Eppendorf AG with Positive First Half-year 2019. Group Sales Grow by 12.8% Percent to €378.5 million". Hamburg....
- [10] Eppendorf AG. (4/25/19). "Press Release: Eppendorf with Worldwide Setting Program. Around 250 Vacancies at All Locations by the End of 2019 – More than 100 New Jobs Planned". Hamburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
![Picture [iito] No Content Marketing 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-content-marketing.jpg)
» top